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Small vessel microembolization and acute
glomerulonephritis following infection of
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Abstract
Background: The systemic consequences of esthetic filler injections are poorly understood.
Case presentation: We report a patient with a past history of subcutaneous injection of aesthetic filler material in
the lower legs, who presented with post-infectious glomerulonephritis following necrotic leg ulcers at the injection
site. Kidney biopsy revealed the presence of translucent, non-birefringent microspherical bodies compatible with
polymethylmetacrylate (PMMA) microspheres in some capillary lumens. This had not previously been described. PMMA
is a biphasic aesthetical filler composed of polymethylmetacrylate microspheres suspended in a biodegradable bovine
collagen carrier. The solid phase (PMMA microspheres) persists in tissues for years. Although PMMA was thought to not
disseminate systemically, tissue necrosis may have favored systemic dissemination of the microspheres, although entry
in the circulation and microembolization at the time of administration cannot be ruled out.
Conclusions: In conclusion, aesthetic filler implants may cause microembolization into small vessels. Recognition of
the characteristic morphology may expedite diagnosis and avoid unnecessary further testing.
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Background
Injected filler agents are used to treat skin wrinkles and
for soft tissue augmentation for cosmetic reasons. How-
ever, fillers may induce adverse inflammatory reactions
that may require biopsy for adequate characterization.
Slowly biodegradable or non-resorbable fillers may cause
severe reactions that may appear years after the injec-
tion, when the patient does not remember which prod-
uct was injected. Histopathology is the gold standard
technique to identify the responsible filler [1]. However,
fillers are thought to remain locally at the site of injec-
tion and unexperienced pathologists may have trouble
identifying the images as aesthetic fillers when found in
an internal organ. This adds to the complexity of provid-
ing an accurate diagnosis as illustrated by this case of
glomerulonephritis following infection of subcutaneous
filler material.
Case presentation
A 57-year-old woman was admitted for painful lower leg
ulcers. Past history included subcutaneous injection of
esthetic filler material in the lower legs 20 years ago,
hypothyroidism and HIV infection on highly active anti-
retroviral therapy (HAART: raltegravir, abacavir, lamivu-
dine). Viral load was negative and CD4 cells were 600/
μl. One year before admission, bilateral torpid lower leg
ulcers developed after minor trauma and progressively
expanded. She was treated with diclofenac.
On admission blood pressure was 190/88 mmHg (previ-
ously normal) and she had extensive necrotic ulceration
and edema in both lower legs. Key lab results were serum
creatinine 1.5 mg/dl (previously 1.0 mg/dl), serum albu-
min 3.5 mg/dl, serum cholesterol 139 mg/dl, complement
factor 3 (C3) nadir 63 mg/dl, normal C4, polyclonal
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hypergammaglobulinemia, urinary albumin:creatinine ratio
2082 mg/g, urinary protein:creatinine ratio 3557 mg/g and
urinary sediment containing 20–40 red blood cells/high
power field. ANCA, ANA, and anti-GBM were negative.
Ulcer cultures grew Group A streptococcus pyogenes.
Kidney biopsy (two cores; 9 and 11 mm long) containing
26 glomeruli, 2 of them completely sclerosed, disclosed dif-
fuse proliferative glomerulonephritis characterized by glom-
erular hypercellularity due to mesangial proliferation and
endocapillary leukocytic infiltration (Fig. 1). Trichrome
staining revealed subepithelial fuchsinophilic deposits. Jones
silver stain did not show spikes or basement membrane re-
duplication (Fig. 2). Coarse mesangial and peripheral capil-
lary loop staining for C3 was seen on immunofluorescence
(Fig. 3), without IgG, IgA or IgM deposition. Round trans-
lucent, non-birefringent microspherical bodies (30–35 μm)
resembling adipocytes were identified within some capillary
lumens (Figs. 1 and 2). Microspheres were also seen in a
globally sclerosed glomerulus (Fig. 2). In the tubulointersti-
tial compartment, intratubular red blood cell casts, acute
tubular damage and patchy interstitial lymphocytic infil-
trates were noted. Vessels showed arteriolar hyalinosis and
moderate myointimal hyperplasia. Ultrastructural study re-
vealed subepithelial deposits (‘humps’) (Fig. 3).
Treatment included local debridement, antibiotics and
angiotensin converting enzyme inhibitors. Estimated glom-
erular filtration rate, C3 and microhematuria normalized at
month 3, 5 and 12, respectively, while albuminuria progres-
sively improved over the next 12 months (Fig. 4). One year
after the initial admission, angiotensin converting enzyme in-
hibitors had been stopped and serum creatinine was 0.9 mg/
dl, estimated glomerular filtration rate 94 ml/min/1.73 m2,
urinary albumin:creatinine ratio 188 mg/g and urinary sedi-
ment contained no red blood cells/high power field.
Discussion
The initial differential diagnosis included acute kidney
injury due to nonsteroidal anti-inflammatory agents,
acute or rapidly progressive glomerulonephritis that may
have been superimposed on prior antiretroviral nephro-
toxicity or chronic HIV-associated glomerulonephritis
[2]. Serological studies and renal biopsy narrowed the
differential diagnosis to acute postinfectious glomerulo-
nephritis or C3 glomerulopathy, while a potential role of
the implanted cosmetic filler material remained unclear.
Morphology of glomerulonephritis with dominant C3
deposits may underlie both post-infectious glomerulo-
nephritis and C3 glomerulopathy, a recently introduced
pathological entity [3]. Currently, C3 glomerulopathy is
defined as a disease process due to abnormal control of
complement activation, deposition, or degradation and
characterized by predominant glomerular C3 deposition
with electron-dense deposits. However, true post-
infectious glomerulonephritis cannot often be differ-
enced from C3 glomerulonephritis based on morpho-
logical, clinical and laboratory data available at the time
of biopsy. Rather, follow-up of clinical parameters,
serum C3 levels and urinary abnormalities over several
months may differentiate both entities [2]. As in the
present case, the decreased serum C3 levels will
normalize over 8–12 weeks in post-infectious glomer-
ulonephritis, although hematuria and albuminuria may
persist for years [4]. The presence of Group A strepto-
coccus pyogenes infection, the time course of kidney
and immunological abnormalities, the renal biopsy and
the absence of evidence of abnormal control of comple-
ment activation, deposition, or degradation, all support a
diagnosis of post-infectious (post-streptococcal) glomerulo-
nephritis. These features also argue against HIV associated
Fig. 1 Diffuse proliferative glomerulonephritis with leukocytic infiltration and polymethyl methacrylate microspheres in glomerular capillary lumens (HE ×400)
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glomerulonephritis. The patient was not taking HAART
drugs that are clearly nephrotoxic, such as tenofovir, indin-
avir or atazanavir [5–7]. In this regard, no evidence of
proximal tubulopathy (tenofovir) or characteristic urine or
kidney tissue crystals (indinavir, atazanavir) were observed
and toxic effects of hematuria may account for tubular in-
jury features observed in the biopsy [8].
The presence of microspheres in the kidney biopsy was
striking. While the patient did not recall the nature of the
injected material, the histologic appearance was consistent
with polymethylmetacrylate (PMMA), a biphasic aesthetical
filler composed of biodegradable bovine collagen and
PMMA microspheres which persist in tissues for years [1].
There is longstanding clinical experience with this material
and only local (subcutaneous) inflammatory granulomatous
reactions are documented [9]. We are not aware of prior
reports of systemic dissemination of PMMA microspheres
in humans. PMMA was thought to not disseminate system-
ically, but it may generate local inflammatory reactions
spontaneously or following a trigger [10, 11]. The injection
of the filler several years ago may explain the absence of a
local kidney inflammatory granulomatous reaction to
Fig. 2 a PMMA microspheres in a glomerulus (Jones silver stain × 400). b The finding of PMMA in a sclerosed glomerulus supports the permanent
nature of this aesthetic filler (HE ×400)
Fig. 3 a Immunofluorescence showing coarse granular C3 deposition along mesangial region with focal peripheral extension adopting a ‘garland’
pattern. b A detail of the glomerular tuft segment between 9 and 11 o’clock. Arrowheads pointing subepithelial deposits that correspond to the
hump-shaped deposits seen by EM (box c). (a: IF anti-C3 ×200; c: TEM ×20000)
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PMMA microspheres, and their presence in a sclerosed
glomerulus supports their permanent nature. The presence
of PMMA in the lower legs may have favored the torpid
course of the ulcers. Conversely, tissue necrosis may have
favored systemic dissemination of the microspheres, al-
though we can only speculate as to their contribution to
the clinical presentation. PMMA does not appear to have
triggered the present inflammatory response since emboli
were present in the absence of local inflammation. How-
ever, it may have contributed to local ischemia and tubular
injury. Entry in the circulation and microembolization at
the time of filler administration, many years ago, cannot be
ruled out.
Conclusions
The final diagnosis was acute post-streptococcal glomer-
ulonephritis with esthetic filler implants microembolization
into small vessels. Esthetic filler implant microembolization
is here described for the first time. We conclude that es-
thetic filler implants may cause microembolization into
small vessels. Recognition of the characteristic morphology
may expedite diagnosis and avoid unnecessary further
testing.
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